BMS-Tempus, Roche-Zymeworks, and LGM-Sannova deals show what AI data, trispecifics, and nitrosamine testing mean for CMC, QA, and development teams.
News|Articles|February 2, 2003
- Pharmaceutical Technology-02-02-2003
- Volume 27
- Issue 2
Outsourcing Outlook
Author(s)Jim Miller
A column covering the outsourcing industry.
Advertisement
Articles in this issue
over 23 years ago
A Stress Testing Benchmarking Studyover 23 years ago
Cleanroom Pressurization Methodologyover 23 years ago
PhRMA Perspectives on Drug Substance Regulatory Filing Issuesover 23 years ago
Manufacturing Capability Key to Global Health Advancesover 23 years ago
February 2003Advertisement
Related to this article
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Nitrosamine Problems and Industry Solutions: PharmTech Explained
2
OpenAI Bets on Accelerating Drug Development Timelines With Orchestra Bio
3
AAPS PharmSci 360 2026: E&L Standards Harmonization
4
AAPS PharmSci 360 2026: System Suitability Standards in E&L Testing
5